MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic Cancer

NCT00769483 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Pancreatic Adenocarcinoma

Interventions

DRUG: MK-0646
DRUG: Gemcitabine
DRUG: Erlotinib

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]